PeptidePedia The community reference

Talk:Fasting insulin

Discussion page·2 threads·no archives

This article is within the scope of the clinical practice working group.

This is the discussion page for the article Fasting insulin. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Four combinationsResolved

Laying out the four insulin-glucose combinations is the clearest way to make the point that neither value alone is interpretable. — PanelPlannerPam (talk) 09:40, 24 February 2026 (UTC)

And it motivates the derived indices rather than presenting them as arbitrary. ✓ Done — HOMA_Hettie (talk) 13:15, 24 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Assay-specific cut-offsDone

"A HOMA-IR threshold quoted without the assay it was derived from is not a threshold" is blunt and right. — LabRangeLindy (talk) 10:20, 17 May 2026 (UTC)

The proinsulin cross-reactivity point explains why, which stops it being an assertion. ✓ Done — SigFigSindri (talk) 13:55, 17 May 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 17 May 2026, by SigFigSindri. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).